Novel bradykinin antagonist dimers for the treatment of human lung cancers

被引：24

作者：

Chan, D

Gera, L

Helfrich, B

Helm, K

Stewart, J

Whalley, E

Bunn, P

机构：

[1] UNIV COLORADO,CTR CANC,DEPT BIOCHEM,DENVER,CO 80262

[2] CORTECH INC,DENVER,CO 80221

来源：

IMMUNOPHARMACOLOGY | 1996年 / 33卷 / 1-3期

关键词：

bradykinin antagonist; dimer; cytotoxic BK dimer; lung cancer; SCLC;

D O I：

10.1016/0162-3109(96)00040-9

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：201 / 204

页数：4

共 7 条

[1]

BECKER KL, 1984, ENDOCRINE LUNG HLTH

[2]

BUNN P, 1992, CANCER RES, P52

[3]

BUNN PA, 1994, CANCER RES, V54, P3602

[4]

BURCH R, 1993, MOL BIOL PHARM BRADY

[5] A new class of potent bradykinin antagonist dimers [J].

Gera, L ;

Stewart, JM ;

Whalley, E ;

Burkard, M ;

Zuzack, JS .

IMMUNOPHARMACOLOGY, 1996, 33 (1-3) :178-182

[6] A new class of bradykinin antagonists containing indanylglycine [J].

Gera, L ;

Stewart, JM .

IMMUNOPHARMACOLOGY, 1996, 33 (1-3) :174-177

[7] DIFFERENTIAL MODULATION OF BOMBESIN-STIMULATED PHOSPHOLIPASE C-BETA AND MITOGEN-ACTIVATED PROTEIN-KINASE ACTIVITY BY [D-ARG(1),D-PHE(5),D-TRP(7,9),LEU(11)] SUBSTANCE-P [J].

MITCHELL, FM ;

HEASLEY, LE ;

QIAN, NX ;

ZAMARRIPA, J ;

JOHNSON, GL .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (15) :8623-8628

← 1 →